TY - JOUR
T1 - Utilization of arterial pulse waveform analysis during non-cardiac surgery in Japan
T2 - a retrospective observational study using a nationwide claims database
AU - Takeda, Chikashi
AU - Takeuchi, Masato
AU - Mizota, Toshiyuki
AU - Yonekura, Hiroshi
AU - Nahara, Isao
AU - Kuwauchi, Aki
AU - Joo, Woo Jin
AU - Kawasaki, Yohei
AU - Kawakami, Koji
N1 - Publisher Copyright:
© 2019, Japanese Society of Anesthesiologists.
PY - 2019/2/20
Y1 - 2019/2/20
N2 - Arterial pulse waveform analysis (APWA) is used for cardiac output monitoring. However, data on the frequency of and patient characteristics for specialized pressure transducer for APWA (S-APWA) use are lacking. We retrospectively identified 175,201 patients aged 18 years or older, who underwent non-cardiac surgery under general anesthesia with an arterial catheter from January 1, 2014, to December 31, 2016. We extracted data on patient demographics, comorbidities, surgical and anesthesia characteristics, and hospital characteristics. Among the full study cohort, 24,605 (14.0%) patients were monitored using S-APWA. Further, the use of S-APWA was higher in patients undergoing high-risk surgery than in those undergoing low-risk surgery [high vs low: adjusted odds ratio (aOR) 1.95; 95% confidence interval (CI) 1.76–2.15, moderate vs low: aOR 1.11; 95% CI 1.01–1.22] and those with more comorbidities than in those with less comorbidities (high vs low: aOR 1.49; 95% CI 1.42–1.56, moderate vs low: aOR 1.25; 95% CI 1.20–1.31). S-APWA use was significantly associated with both surgery risk and patients’ comorbidities. In conclusion, our study may provide a benchmark for future studies related to the appropriate use of S-APWA.
AB - Arterial pulse waveform analysis (APWA) is used for cardiac output monitoring. However, data on the frequency of and patient characteristics for specialized pressure transducer for APWA (S-APWA) use are lacking. We retrospectively identified 175,201 patients aged 18 years or older, who underwent non-cardiac surgery under general anesthesia with an arterial catheter from January 1, 2014, to December 31, 2016. We extracted data on patient demographics, comorbidities, surgical and anesthesia characteristics, and hospital characteristics. Among the full study cohort, 24,605 (14.0%) patients were monitored using S-APWA. Further, the use of S-APWA was higher in patients undergoing high-risk surgery than in those undergoing low-risk surgery [high vs low: adjusted odds ratio (aOR) 1.95; 95% confidence interval (CI) 1.76–2.15, moderate vs low: aOR 1.11; 95% CI 1.01–1.22] and those with more comorbidities than in those with less comorbidities (high vs low: aOR 1.49; 95% CI 1.42–1.56, moderate vs low: aOR 1.25; 95% CI 1.20–1.31). S-APWA use was significantly associated with both surgery risk and patients’ comorbidities. In conclusion, our study may provide a benchmark for future studies related to the appropriate use of S-APWA.
UR - https://www.scopus.com/pages/publications/85059650317
UR - https://www.scopus.com/pages/publications/85059650317#tab=citedBy
U2 - 10.1007/s00540-018-02609-x
DO - 10.1007/s00540-018-02609-x
M3 - Article
C2 - 30617547
AN - SCOPUS:85059650317
SN - 0913-8668
VL - 33
SP - 159
EP - 162
JO - Journal of Anesthesia
JF - Journal of Anesthesia
IS - 1
ER -